September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Vitreous Bacterial Cultures and Antibiotic Susceptibility Report for University of Nebraska Medical Center, Omaha, Nebraska, 2000-2014
Author Affiliations & Notes
  • Jonathan Crews
    Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, United States
  • Diana V Do
    Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, United States
  • R Joel Welch
    Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, United States
  • Footnotes
    Commercial Relationships   Jonathan Crews, None; Diana Do, Allergen (C), Genentech (C), Regeneron (C), Santen (C); R Joel Welch, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 5875. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Jonathan Crews, Diana V Do, R Joel Welch; Vitreous Bacterial Cultures and Antibiotic Susceptibility Report for University of Nebraska Medical Center, Omaha, Nebraska, 2000-2014. Invest. Ophthalmol. Vis. Sci. 2016;57(12):5875.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate the frequency of bacterial species that were cultured from vitreous specimens during a fifteen-year period. To establish an antibiotic susceptibility report for vitreous bacterial cultures obtained over this period. The data are also analyzed in 5-year trends in order to assess if changes have taken place in microbial prevalence and with antibiotic susceptibilities.

Methods : This is a retrospective analysis. Data was obtained from the microbiology department from results of vitreous bacterial cultures from January 1, 2000 to June 8, 2014. Charts were not reviewed and protected health information was not disclosed; therefore, institutional review board was not utilized.

Results : 92 positive vitreous bacterial cultures and antibiotic susceptibilities to clinically relevant antibiotics were analyzed. The frequency of bacterial species are as follows: coagulase-negative Staphylococcus (49/92, 53.3%), of those, 30.6% were Staph. epidermidis; Viridans group Streptococcus (13/92, 14.1%); Enterococcus faecalis (7/92, 7.6%); Strep. pneumoniae (4/92, 4.3%); MSSA (6/92, 6.5%); MRSA (3/92, 3.3%); Proteus mirabilis (3/92, 3.3%); Bacillus species (2/92, 2.2%); Corynebacterium species, E. coli, Klebsiella pneumoniae, Bacteroides fragilis and Moraxella catarrhalis (each 1, 1.1%).
The results are partitioned into three groups according to 5-year periods (2000-04, 2005-09 and 2010-14). The 3 tables in Figure 1 display the results. Of note, ciprofloxacin susceptibility decreased from 63.6 to 50.0 to 25.0% during the three 5-year periods. Levofloxacin susceptibility decreased from 79.5 to 64.7 to 46.2%. Moxifloxacin susceptibility decreased from 77.8 to 66.7 to 47.1%. Gatifloxacin susceptibility decreased from 80.0 to 70.0% during the first two 5-year periods.

Conclusions : Establishing a susceptibility report for the hospital provides valuable data for ophthalmic practitioners who practice in this region. The data can also be compared to vitreous bacterial cultures from other regions. The analysis provides trends of antibiotic susceptibilities and, in doing so, displays a decrease in susceptibility among all generations of fluoroquinolones. This is interesting to note because fluoroquinolones are routinely used topically to prevent post-cataract endophthalmitis and systemically to prevent post-traumatic endophthalmitis in the setting of globe trauma.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×